Literature DB >> 8707387

Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis.

C N Alexander1, R H Schneider, F Staggers, W Sheppard, B M Clayborne, M Rainforth, J Salerno, K Kondwani, S Smith, K G Walton, B Egan.   

Abstract

Our objective was to test the short-term efficacy and feasibility of two stress-reduction approaches for the treatment of hypertension in older African Americans, focusing on subgroup analysis by sex and by high and low risk on six measures of hypertension risk: psychosocial stress, obesity, alcohol use, physical inactivity, dietary sodium-potassium ratio, and a composite measure. The study involved a follow-up subgroup analysis of a 3-month randomized, controlled, single-blind trial conducted in a primary care, inner-city health center. Subjects were 127 African American men and women, aged 55 to 85 years, with diastolic pressure of 90 to 104 mm Hg and systolic pressure less than or equal to 179 mm Hg. Of these, 16 did not complete follow-up blood pressure measurements. Mental and physical stress-reduction approaches-the Transcendental Meditation technique and progressive muscle relaxation, respectively-were compared with a life-style modification education control and with each other. Both systolic and diastolic pressures changed from baseline to follow-up for both sexes and for high and low risk level (defined by median split) on the six measures of hypertension risk. Compared with education control subjects, women practicing the Transcendental Meditation technique showed adjusted declines in systolic (10.4 mm Hg, P < .01) and diastolic (5.9 mm Hg, P < .01) pressures. Men in this treatment group also declined in both systolic (12.7 mm Hg, P < .01) and diastolic (8.1 mm Hg, P < .001) pressures compared with control subjects. Women practicing muscle relaxation did not show a significant decrease compared with control subjects, and men declined significantly in diastolic pressure only (6.2 mm Hg, P < .01). For the measure of psychosocial stress, both the high and low risk subgroups using the Transcendental Meditation technique declined in systolic (high risk, P = .0003; low, P = .06) and diastolic (high risk, P = .001; low, P = .008) pressures compared with control subjects, whereas for muscle relaxation, blood pressure dropped significantly only in the high risk subgroup and only for systolic pressure (P = .03) compared with control subjects. For each of the other five risk measures, Transcendental Meditation subjects in both the high and low risk groups declined significantly in systolic and diastolic pressures compared with control subjects. Effects of stress reduction on blood pressure were found to generalize to both sexes and diverse risk factor subgroups and were significantly greater in the Transcendental Meditation treatment group. These effects (along with high compliance) even in individuals with multiple risk factors for hypertension clearly warrant longer-term investigation in this and other populations.

Entities:  

Mesh:

Year:  1996        PMID: 8707387     DOI: 10.1161/01.hyp.28.2.228

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

Review 1.  Review of controlled research on the transcendental meditation program and cardiovascular disease. Risk factors, morbidity, and mortality.

Authors:  Kenneth G Walton; Robert H Schneider; Sanford Nidich
Journal:  Cardiol Rev       Date:  2004 Sep-Oct       Impact factor: 2.644

2.  Effects of spiritual mantram repetition on HIV outcomes: a randomized controlled trial.

Authors:  Jill E Bormann; Allen L Gifford; Martha Shively; Tom L Smith; Laura Redwine; Ann Kelly; Sheryl Becker; Madeline Gershwin; Patricia Bone; Wendy Belding
Journal:  J Behav Med       Date:  2006-07-18

3.  Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study.

Authors:  Ravishankar Jayadevappa; Jerry C Johnson; Bernard S Bloom; Sanford Nidich; Shashank Desai; Sumedha Chhatre; Donna B Raziano; Robert Schneider
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

4.  Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.

Authors:  Helen Lavretsky; Lily L Alstein; Richard E Olmstead; Linda M Ercoli; Marquertie Riparetti-Brown; Natalie St Cyr; Michael R Irwin
Journal:  Am J Geriatr Psychiatry       Date:  2011-10       Impact factor: 4.105

Review 5.  Stress, stress reduction, and hypertension in African Americans: an updated review.

Authors:  V Barnes; R Schneider; C Alexander; F Staggers
Journal:  J Natl Med Assoc       Date:  1997-07       Impact factor: 1.798

6.  Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2006-08-01

Review 7.  Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi consciousness-based health care.

Authors:  Robert H Schneider; Kenneth G Walton; John W Salerno; Sanford I Nidich
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

8.  Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2012-08

9.  Knowledge, beliefs, and behaviors about hypertension control among middle-aged Korean Americans with hypertension.

Authors:  Hae-Ra Han; Kim B Kim; Jeonghee Kang; Seonghee Jeong; Eun-Young Kim; Miyong T Kim
Journal:  J Community Health       Date:  2007-10

10.  Turo (qi dance) training attenuates psychological symptoms and sympathetic activation induced by mental stress in healthy women.

Authors:  Hwa-Jin Lee; Younbyoung Chae; Hi-Joon Park; Dae-Hyun Hahm; Kyungeh An; Hyejung Lee
Journal:  Evid Based Complement Alternat Med       Date:  2007-11-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.